Results 1 to 10 of about 15,029 (142)

Adherence to Oral Anticancer Medications: Evolving Interprofessional Roles and Pharmacist Workforce Considerations [PDF]

Pharmacy, 2018
Interprofessional care is exhibited in outpatient oncology practices where practitioners from a myriad of specialties (e.g., oncology, nursing, pharmacy, health informatics and others) work collectively with patients to enhance therapeutic outcomes and ...
Gennaro A. Paolella, Andrew D. Boyd, Scott M. Wirth, Sandra Cuellar, Neeta K. Venepalli, Stephanie Y. Crawford   +5 more
doaj   +3 more sources

Adherence to Oral Anticancer Medications Among Women With Breast Cancer in Africa: A Scoping Review

JCO Global Oncology, 2023
PURPOSEOral anticancer medications (OAMs) improve treatment outcomes and survival in women with breast cancer (BC). However, adherence to OAM therapy remains suboptimal.
Deborah O. Onwusah, Elizabeth B. Ojewole, Moses J. Chimbari   +2 more
doaj   +3 more sources

A Novel Approach to Better Characterize Medication Adherence in Oral Anticancer Treatments [PDF]

Frontiers in Pharmacology, 2019
Purpose: This study aims to describe a 12-month medication adherence with oral anticancer medications (OAMs) in a routine care medication adherence program, and to better characterize non-persistence.Patients and methods:In this observational, one ...
Marie Paule Schneider, Marie Paule Schneider, Leila Achtari Jeanneret, Bernard Chevaux, Claudine Backes, Anna Dorothea Wagner, Olivier Bugnon, Olivier Bugnon, François Luthi, Isabella Locatelli   +9 more
doaj   +5 more sources

Impact of Patient Personality on Adherence to Oral Anticancer Medications: An Opportunity?

JMIR Cancer
Adherence to prescribed oral anticancer therapy is an important determinant of patient outcomes, including progression-free and overall survival.
Mahtab Jafari, Alex Shahverdian, Gelareh Sadigh, Richard A Van Etten   +3 more
doaj   +3 more sources

Current management of adults receiving oral anti-cancer medications: A scoping review protocol [version 2; peer review: 1 approved, 2 approved with reservations]

HRB Open Research, 2021
Oncology has been undergoing a profound transition in the last ten years with the increased usage in oral anti-cancer medication. Approximately 25% of all anti-cancer medication is now designed for oral use and this is likely to increase prospectively ...
Mary Grace Kelly, Janice P. Richmond, Lisa Hynes, Alison Johnston, Andrew W. Murphy, Patrick J. Murphy   +5 more
doaj   +1 more source

Current management of adults receiving oral anti-cancer medications: A scoping review protocol [version 3; peer review: 2 approved, 1 approved with reservations]

HRB Open Research, 2022
Oncology has been undergoing a profound transition in the last ten years with the increased usage in oral anti-cancer medication. Approximately 25% of all anti-cancer medication is now designed for oral use and this is likely to increase prospectively ...
Mary Grace Kelly, Janice P. Richmond, Lisa Hynes, Alison Johnston, Andrew W. Murphy, Patrick J. Murphy   +5 more
doaj   +1 more source

Current management of adults receiving oral anti-cancer medications: A scoping review protocol [version 4; peer review: 2 approved, 1 approved with reservations]

HRB Open Research, 2022
Oncology has been undergoing a profound transition in the last ten years with the increased usage in oral anti-cancer medication. Approximately 25% of all anti-cancer medication is now designed for oral use and this is likely to increase prospectively ...
Mary Grace Kelly, Janice P. Richmond, Lisa Hynes, Alison Johnston, Andrew W. Murphy, Patrick J. Murphy   +5 more
doaj   +1 more source

A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol.

PLoS ONE, 2021
BackgroundPatients with haematologic malignancies are increasingly treated by oral anticancer medications, heightening the challenge of ensuring optimal adherence to treatment. However, except for chronic myelogenous leukaemia or acute lymphoid leukaemia,
Sandra Michiels, Sandra Tricas-Sauras, Marie Dauvrin, Dominique Bron, Fati Kirakoya-Samadoulougou   +4 more
doaj   +1 more source

Interventions for the Prevention of Oral Mucositis in Patients Receiving Cancer Treatment: Evidence from Randomised Controlled Trials

Current Oncology, 2023
Oral mucositis is a common and most debilitating complication associated with cancer therapy. Despite the significant clinical and economic impact of this condition, there is little to offer to patients with oral mucositis, and the medications used in ...
Giuseppe Colella, Ciro Emiliano Boschetti, Rita Vitagliano, Chiara Colella, Lebei Jiao, Natalie King-Smith, Chong Li, Yii Nuoh Lau, Zacchaeus Lai, Ali Ibrahim Mohammed, Nicola Cirillo   +10 more
doaj   +1 more source

Examining adherence to oral anticancer medications through a human factors engineering framework: Protocol for a scoping review.

PLoS ONE, 2022
BackgroundThe number of oral anticancer medications has increased over the past few decades, opening new possibilities in cancer care and improving convenience for patients and caregivers.
Irene D Lin, Matthew B Shotts, Ahmad Al-Hader, Kellie Jones Weddle, Richard J Holden, Emily L Mueller, Monica R Macik, Mirian Ramirez, Ephrem Abebe   +8 more
doaj   +1 more source